Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Invested Capital (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Return on Invested Capital for 16 consecutive years, with 0.26% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 26.0% to 0.26% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, down 26.0% year-over-year, with the annual reading at 0.22% for FY2025, 23.0% down from the prior year.
  • Return on Invested Capital hit 0.26% in Q4 2025 for Integra Lifesciences Holdings, down from 0.25% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.08% in Q2 2021 to a low of 0.26% in Q4 2025.
  • Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.06% in 2021.
  • Biggest five-year swings in Return on Invested Capital: rose 9bps in 2021 and later fell -26bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.06% in 2021, then grew by 27bps to 0.08% in 2022, then tumbled by -50bps to 0.04% in 2023, then plummeted by -88bps to 0.0% in 2024, then plummeted by -5517bps to 0.26% in 2025.
  • Business Quant data shows Return on Invested Capital for IART at 0.26% in Q4 2025, 0.25% in Q3 2025, and 0.22% in Q2 2025.